Treatment types recommended for consideration in adjuvant or neoadjuvant early breast cancer included chemotherapy, anti-HER2 therapy, other targeted therapy, endocrine therapy, bisphosphonates and radiotherapy (Table 1). The gene discussed is ERBB2; the disease is breast cancer.